Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer The authors present a score that ...
“The ability of the large language models, and other AI systems to make meaningful contributions to academic work may justify future co-authorship on academic perspective, review and research papers.” ...
Businessman chatting with AI technology or artificial intelligence Q&A chat via A.I., the future technology in online system. 3d render illustration. We have all heard the recent hype around the new ...
“It’s almost like an infant,” says Jonathan Bickoff. It’s a refreshingly simple take on one of the most tortured topics currently getting bandied about among La Jolla’s digi-pioneering crowd: AI.
Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer Precision oncology in non–small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results